Unlocking the Mysteries of Cryptogenic Stroke: the Role of Long-term Cardiac Rhythm Monitoring

Overview

Journal Future Cardiol

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 23

PMID 39041542

Authors

Panteleimon E Papakonstantinou

Affiliations

Soon will be listed here.

References

Page R, WILKINSON W, Clair W, McCarthy E, Pritchett E . Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994; 89(1):224-7. DOI: 10.1161/01.cir.89.1.224. View

Diener H, Sacco R, Easton J, Granger C, Bernstein R, Uchiyama S . Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 2019; 380(20):1906-1917. DOI: 10.1056/NEJMoa1813959. View

Dilaveris P, Antoniou C, Caiani E, Casado-Arroyo R, Climent A, Cluitmans M . ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients: In collaboration with the Council on Stroke, the European Heart Rhythm.... Eur Heart J Digit Health. 2023; 3(3):341-358. PMC: 9707962. DOI: 10.1093/ehjdh/ztac026. View

Sanna T, Diener H, Passman R, Di Lazzaro V, Bernstein R, Morillo C . Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014; 370(26):2478-86. DOI: 10.1056/NEJMoa1313600. View

Svennberg E, Tjong F, Goette A, Akoum N, Di Biase L, Bordachar P . How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022; 24(6):979-1005. PMC: 11636571. DOI: 10.1093/europace/euac038. View

Gladstone D, Spring M, Dorian P, Panzov V, Thorpe K, Hall J . Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014; 370(26):2467-77. DOI: 10.1056/NEJMoa1311376. View

Hart R, Sharma M, Mundl H, Kasner S, Bangdiwala S, Berkowitz S . Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018; 378(23):2191-2201. DOI: 10.1056/NEJMoa1802686. View

Simantirakis E, Papakonstantinou P, Chlouverakis G, Kanoupakis E, Mavrakis H, Kallergis E . Asymptomatic versus symptomatic episodes in patients with paroxysmal atrial fibrillation via long-term monitoring with implantable loop recorders. Int J Cardiol. 2017; 231:125-130. DOI: 10.1016/j.ijcard.2016.12.025. View

Simantirakis E, Papakonstantinou P, Kanoupakis E, Chlouverakis G, Tzeis S, Vardas P . Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring. Clin Cardiol. 2018; 41(5):594-600. PMC: 6489953. DOI: 10.1002/clc.22904. View

10.

Papakonstantinou P, Kalogera V, Charitos D, Polyzos D, Benia D, Batsouli A . When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer. Blood Rev. 2024; 65:101171. DOI: 10.1016/j.blre.2024.101171. View

11.

Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F . Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes: A Systematic Review and Meta-Analysis. Stroke. 2018; 49(4):814-819. DOI: 10.1161/STROKEAHA.117.020031. View

12.

Brambatti M, Connolly S, Gold M, Morillo C, Capucci A, Muto C . Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014; 129(21):2094-9. DOI: 10.1161/CIRCULATIONAHA.113.007825. View

13.

Kirchhof P, Toennis T, Goette A, Camm A, Diener H, Becher N . Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. N Engl J Med. 2023; 389(13):1167-1179. DOI: 10.1056/NEJMoa2303062. View

14.

Van Gelder I, Healey J, Crijns H, Wang J, Hohnloser S, Gold M . Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017; 38(17):1339-1344. DOI: 10.1093/eurheartj/ehx042. View

15.

Healey J, Lopes R, Granger C, Alings M, Rivard L, McIntyre W . Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N Engl J Med. 2023; 390(2):107-117. DOI: 10.1056/NEJMoa2310234. View

16.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

17.

Svendsen J, Diederichsen S, Hojberg S, Krieger D, Graff C, Kronborg C . Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021; 398(10310):1507-1516. DOI: 10.1016/S0140-6736(21)01698-6. View

18.

Healey J, Connolly S, Gold M, Israel C, Van Gelder I, Capucci A . Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366(2):120-9. DOI: 10.1056/NEJMoa1105575. View

19.

Papakonstantinou P, Tsioufis K . Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom?. J Cardiovasc Pharmacol. 2023; 81(6):397-399. DOI: 10.1097/FJC.0000000000001405. View

20.

Papakonstantinou P, Simantirakis E . Long-term rhythm monitoring with an implantable loop recorder in patients after the first clinical atrial fibrillation episode. Towards an individualized management. Minerva Cardioangiol. 2019; 67(2):121-130. DOI: 10.23736/S0026-4725.19.04883-7. View